• Int J Palliat Nurs · Oct 2015

    Comparing the effectiveness of intranasal fentanyl spray with oral transmucosal fentanyl citrate in breakthrough pain.

    • Sarah E Shellard and Felix S F Ram.
    • Clinical Nurse Specialist, Te Omanga Hospice, Lower Hutt, New Zealand.
    • Int J Palliat Nurs. 2015 Oct 1; 21 (10): 475-8.

    BackgroundBreakthrough cancer pain (BTCP) is complex and severe, affecting quality of life and increasing hospitalisation. BTCP has a rapid onset that requires fast acting medication with minimal side effects.AimThis article compares the effectiveness of intranasal fentanyl spray (INFS) and oral transmucosal fentanyl citrate (OTFC) and their alleviation of BTCP within 10 minutes of administration.MethodThe article considers pharmacokinetic and bioavailability studies demonstrating the efficacy of the route of administration, time-based effects of pain relief as well as patient preference.ConclusionThe data collected indicates that INFS is more effective than OTFC for BTCP.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…